The European Dyspnoea survey in the Emergency departments
Epidemiologic description of patients presenting to the ED with shortness of breath as main complaint.
Prospective multicentre observational study
Assessing tranexamic acid after hyperacute spontaneous intracerebral haemorrhage.
Tranexamic Acid for Hyperacute Primary IntraCerebral Haemorrhage
Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial
Tranexamic acid for the treatment of gastrointestinal haemorrhage
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.
RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax